#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3336	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2092	282.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1662	1662	T	322	T	184	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3336	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2092	282.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1396	1396	C	404	C	247	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5962	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3517	288.9	0	.	n	.	0	A9G	SNP	9	9	A	371	371	G	290	G	172	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5962	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3517	288.9	0	.	n	.	0	T695C	SNP	695	695	T	1057	1057	C	447	C	249	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5962	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3517	288.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2333	2333	C	287	C	172	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5962	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3517	288.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2959	2959	T	316	T	187	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5962	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3517	288.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2407	2407	A	292	A	168	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	178	folP	855	855	99.77	folP.l15.c4.ctg.1	1253	25.2	1	SNP	p	R229S	1	.	.	685	687	AGC	916	918	AGC	51;52;51	A;G;C	31;32;31	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	584	gyrA	2751	2306	99.74	gyrA.l15.c4.ctg.1	2567	34.8	0	.	p	.	0	T243I	NONSYN	727	729	ACA	911	913	ATA	37;37;29	A;T;A	24;21;15	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	584	gyrA	2751	2306	99.74	gyrA.l15.c4.ctg.1	2567	34.8	0	.	p	.	0	M250I	NONSYN	748	750	ATG	932	934	ATA	29;29;29	A;T;A	17;17;17	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	584	gyrA	2751	2306	99.74	gyrA.l15.c4.ctg.1	2567	34.8	1	SNP	p	S91F	0	.	.	271	273	TCC	455	457	TCC	43;43;43	T;C;C	24;24;24	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	584	gyrA	2751	2306	99.74	gyrA.l15.c4.ctg.1	2567	34.8	1	SNP	p	D95N	0	.	.	283	285	GAC	467	469	GAC	44;46;46	G;A;C	25;25;26	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	584	gyrA	2751	2306	99.74	gyrA.l15.c4.ctg.1	2567	34.8	1	SNP	p	D95G	0	.	.	283	285	GAC	467	469	GAC	44;46;46	G;A;C	25;25;26	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	584	gyrA	2751	446	100.0	gyrA.l15.c4.ctg.2	630	25.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	531	142	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	934	26.4	0	.	p	.	0	P191fs	FSHIFT	571	571	C	736	736	C	25	C	15	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	531	142	mtrR	633	633	99.69	mtrR.l15.c4.ctg.1	934	26.4	1	SNP	p	G45D	0	.	.	133	135	GGC	297	299	GGC	23;24;24	G;G;C	14;13;12	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	110	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	729	24.1	0	.	n	.	0	.206T	INS	206	206	T	317	317	T	34	T	21	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	500	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2615	32.3	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1388	1390	GCC	20;21;21	G;C;C	13;13;12	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	500	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2615	32.3	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1430	1432	GCA	20;20;20	G;C;A	14;12;12	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	500	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2615	32.3	1	SNP	p	D86N	0	.	.	256	258	GAC	383	385	GAC	44;44;44	G;A;C	27;21;28	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	500	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2615	32.3	1	SNP	p	S87R	0	.	.	259	261	AGT	386	388	AGT	43;45;43	A;G;T	23;27;25	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	500	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2615	32.3	1	SNP	p	S87W	0	.	.	259	261	AGT	386	388	AGT	43;45;43	A;G;T	23;27;25	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	500	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2615	32.3	1	SNP	p	S87I	0	.	.	259	261	AGT	386	388	AGT	43;45;43	A;G;T	23;27;25	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	500	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2615	32.3	1	SNP	p	S88P	0	.	.	262	264	TCC	389	391	TCC	43;43;43	T;C;C	23;26;27	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	444	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2863	27.6	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1837	1839	GGT	30;32;32	G;G;T	17;19;18	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1239	1241	GCA	68;71;72	G;C;A	39;42;42	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1242	1244	ATC	72;72;73	A;T;C,T	45;44;42,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1254	1256	GTG	70;70;70	G;T;G	41;41;41	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1254	1256	GTG	70;70;70	G;T;G	41;41;41	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1758	1760	ACC	31;32;32	A;C;C	18;20;21	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1812	1814	GCG	30;30;30	G;C;G	19;17;19	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1812	1814	GCG	30;30;30	G;C;G	19;17;19	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1935	1937	GGT	38;38;38	G;G;T	23;24;24	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1944	1946	GGC	36;36;36	G;G;C	22;22;21	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	562	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2331	41.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1962	1964	CCG	37;37;37	C;C;G	21;23;20	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1096	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3230	53.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1677	1679	CTG	37;37;37	C;T;G	21;19;21	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	324	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1982	30.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	493	495	GGC	24;24;26	G;G;C	18;20;20	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	324	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1982	30.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	675	675	C	28	C	14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	32	porB1a	984	207	94.2	porB1a.l15.c4.ctg.2	211	5.0	0	.	p	.	0	T250S	NONSYN	748	750	ACC	39	41	AGC	4;4;4	A;G;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	32	porB1a	984	207	94.2	porB1a.l15.c4.ctg.2	211	5.0	0	.	p	.	0	A251V	NONSYN	751	753	GCG	42	44	GTG	4;4;4	G;T;G	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	32	porB1a	984	207	94.2	porB1a.l15.c4.ctg.2	211	5.0	0	.	p	.	0	S271T	NONSYN	811	813	TCG	102	104	ACT	6;6;6	A;C;T	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	32	porB1a	984	207	94.2	porB1a.l15.c4.ctg.2	211	5.0	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	108	110	GAT	6;6;6	G;A;T	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	32	porB1a	984	207	94.2	porB1a.l15.c4.ctg.2	211	5.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	111	113	AGT	6;6;6	A;G;T	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	32	porB1a	984	207	94.2	porB1a.l15.c4.ctg.2	211	5.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	120	122	TAC	6;6;8	T;A;C	3;3;4	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	T18M	NONSYN	52	54	ACG	267	269	ATG	26;26;26	A;T;G	17;14;15	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	348	350	GTT	36;36;36	G;T;T	19;21;22	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	N121S	NONSYN	361	363	AAC	576	578	AGC	36;36;36	A;G;C	21;19;20	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	579	581	AAA	36;36;36	A;A;A	21;22;21	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	606	608	TAT	35;35;35	T;A;T	16;20;19	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	N134K	NONSYN	400	402	AAT	615	617	AAG	31;31;31	A;A;G	17;17;15	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	V135F	NONSYN	403	405	GTG	618	620	TTT	31;31;31	T;T;T	17;17;18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	633	635	AAA	31;31;31	A;A;A	16;17;16	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	642	644	GAA	31;32;32	G;A;A	17;16;18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	666	668	GCA	41;41;41	G;C;A	24;24;24	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	K207_M208insK	INS	619	619	A	834	834	A	29	A	18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	A212S	NONSYN	634	636	GCA	852	854	TCA	38;40;40	T,G;C;A	20,1;22;22	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	260	porB1b	1038	1038	96.37	porB1b.l15.c4.ctg.1	1457	31.9	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	969	969	T	40	T	22	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	22	porB3	990	206	94.17	porB3.l15.c4.ctg.1	211	5.0	0	.	p	.	0	T252S	NONSYN	754	756	ACC	39	41	AGC	4;4;4	A;G;C	2;2;2	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	22	porB3	990	206	94.17	porB3.l15.c4.ctg.1	211	5.0	0	.	p	.	0	L253V	NONSYN	757	759	TTG	42	44	GTG	4;4;4	G;T;G	2;2;2	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	22	porB3	990	206	94.17	porB3.l15.c4.ctg.1	211	5.0	0	.	p	.	0	S273T	NONSYN	817	819	TCG	102	104	ACT	6;6;6	A;C;T	3;3;3	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	22	porB3	990	206	94.17	porB3.l15.c4.ctg.1	211	5.0	0	.	p	.	0	D276S	NONSYN	826	828	GAT	111	113	AGT	6;6;6	A;G;T	3;3;3	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	22	porB3	990	206	94.17	porB3.l15.c4.ctg.1	211	5.0	0	.	p	.	0	K278D	NONSYN	832	834	AAA	117	119	GAC	6;6;6	G;A;C	3;3;3	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	22	porB3	990	206	94.17	porB3.l15.c4.ctg.1	211	5.0	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	120	122	TAC	6;6;8	T;A;C	3;3;4	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	1530	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4506	57.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1774	1776	CAT	59;57;57	C;A;T	36;33;34	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	114	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	745	28.7	1	SNP	p	V57M	1	.	.	169	171	ATG	387	389	ATG	49;47;47	A;T;G	29;28;28	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
